CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.
about
Definition of the stage of host cell genetic restriction of replication of human immunodeficiency virus type 1 in monocytes and monocyte-derived macrophages by using twins.Determining the invariant structure elements of the HIV-1 variable V3 loops: insight into the HIV-MN and HIV-Haiti isolates.Conformational preferences of the HIV-1 principal neutralizing determinant.Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.Conformational model for the consensus V3 loop of the envelope protein gp120 of HIV-1 in a 20% trifluoroethanol/water solution.Probing sequence variation in the receptor-targeting domain of feline leukemia virus envelope proteins with peptide display libraries.HIV-1 envelope determinants for cell tropism and chemokine receptor use.Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target.Analysis of the critical domain in the V3 loop of human immunodeficiency virus type 1 gp120 involved in CCR5 utilization.trans-dominant interference with human immunodeficiency virus type 1 replication and transmission in CD4(+) cells by an envelope double mutant.N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropismWild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals.Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine designConstruction and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular clone.Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein.Syndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agent.Identification of conserved and variable structures in the human immunodeficiency virus gp120 glycoprotein of importance for CXCR4 bindingEffect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization.Hypervariable region 3 residues of HIV type 1 gp120 involved in CCR5 coreceptor utilization: therapeutic and prophylactic implications.Human immunodeficiency virus-1 gp120 V3 loop for anti-acquired immune deficiency syndrome drug discovery: computer-aided approaches to the problem solving.Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease.Conserved determinants of enhanced CCR5 binding in the human immunodeficiency virus subtype D envelope third variable loop.Mutations in the V3 stem versus the V3 crown and C4 region have different effects on the binding and fusion steps of human immunodeficiency virus type 1 gp120 interaction with the CCR5 coreceptor.A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs.A Prominent Site of Antibody Vulnerability on HIV Envelope Incorporates a Motif Associated with CCR5 Binding and Its Camouflaging Glycans.In silico design of novel broad anti-HIV-1 agents based on glycosphingolipid β-galactosylceramide, a high-affinity receptor for the envelope gp120 V3 loop.Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.Structural analysis of the envelope gp120 V3 loop for some HIV-1 variants circulating in the countries of Eastern Europe.
P2860
Q27469707-E04AFD94-78EF-4798-ADD8-BE6FA8ABE9C9Q30370415-912727AC-24F8-410E-9231-553E46262008Q31010762-4E179184-07AC-4941-A7C8-A1EAEB6D590BQ31112947-D5E99987-4D6D-43B4-A2B2-8FDD2D5C9ED7Q31143293-0F776DB6-FAE0-4AF8-B43D-BA0816643C57Q31911259-D5B1B750-E694-4B63-9E6F-5826B0457131Q33210857-40475692-FE41-4734-96CA-0ED0CC721B1FQ33637946-93224ADF-D793-419D-B7CC-980E86D01D7EQ33639712-B2A193C7-06B7-47A5-B65F-0792843986C9Q33819515-D0D62664-E553-43C5-94EB-0B2F2A65D692Q33819782-8BE6FE3D-08BE-4540-AE95-C9627E9630F7Q33842455-7FA77A4A-3318-470B-8985-5D6B97785BA9Q33843329-0A8DA724-34E7-452E-8169-75E50E9D378BQ33845527-00BF51AF-A210-40E8-8667-54EB9BBDEB43Q33851598-6B61694A-4764-40F0-A318-B12081B0EDAAQ33851913-E30BEA4E-4A8C-4851-8864-0B65A5E92D6EQ33962742-E1584D1F-05B5-47D8-B55E-3AD9F1DA945EQ34349528-64A1A394-AC37-4CB5-B626-FD6CFCAD9C43Q34744722-350DFA4F-03B1-4578-8412-78525F2298CBQ35132239-28CF5FC8-FBAD-4DB2-B799-6989C9BA80B0Q38014473-B0D0A664-D12F-4698-9447-FF9D7C034503Q38620316-88C089F5-2826-496A-905C-A5915A20B533Q39717223-20EC206C-723E-4C9A-A8A1-B00B75813446Q40209126-70C61373-5393-45D2-AEF0-A25525CDE473Q40374556-7DDC9E56-BD1E-4C62-AC30-6C09D54BE495Q40606158-75CB21F0-B122-4500-BE28-947CD33872D3Q42211561-1F658359-8340-46DF-818B-69C286EEA4A2Q44111505-9EF50C62-6C84-4EE0-8129-1C6021987F00Q47269444-0E8E06FA-0C78-4514-A5D0-E5BB519C5056
P2860
CCR5 coreceptor utilization involves a highly conserved arginine residue of HIV type 1 gp120.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
CCR5 coreceptor utilization in ...... e residue of HIV type 1 gp120.
@ast
CCR5 coreceptor utilization in ...... e residue of HIV type 1 gp120.
@en
type
label
CCR5 coreceptor utilization in ...... e residue of HIV type 1 gp120.
@ast
CCR5 coreceptor utilization in ...... e residue of HIV type 1 gp120.
@en
prefLabel
CCR5 coreceptor utilization in ...... e residue of HIV type 1 gp120.
@ast
CCR5 coreceptor utilization in ...... e residue of HIV type 1 gp120.
@en
P2093
P2860
P356
P1476
CCR5 coreceptor utilization in ...... e residue of HIV type 1 gp120.
@en
P2093
P2860
P304
P356
10.1073/PNAS.95.10.5740
P407
P577
1998-05-01T00:00:00Z